E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/27/2010 in the Prospect News PIPE Daily.

Medgenics issues an extra $1 million convertibles for $4 million total

Private offering places one-year 4% debentures with multiple investors

By Devika Patel

Knoxville, Tenn., Sept. 27 - Medgenics, Inc. said it took in $4 million through a private placement of 4% convertible unsecured debentures. The offering priced for between $1 million and $3 million on Aug. 24.

The debentures mature in one year and are convertible into shares at 13p. The conversion price represents a 57.58% premium to the 8.25p closing share price on Aug. 23.

The debentures will automatically convert upon the company completing an underwritten public offering of stock which raises at least $6 million at a conversion price equal to the lesser of 13p and 75% of the public offering price of the stock.

Investors also received 75% warrant coverage. The warrants will be exercisable at 16p for five years. The strike price reflects a 93.94% premium to the closing share price on Aug. 23.

Investors included the Kanter Family Foundation and CIBC Trust Co. (Bahamas) Ltd., which each purchased $100,000 of debentures. In addition, Chicago Investments, Inc. purchased $50,000 of debentures.

Based in Vienna, Va., Medgenics is a biotechnology company and developer of associated medical equipment.

Issuer:Medgenics, Inc.
Issue:Convertible unsecured debentures
Amount:$4 million
Maturity:One year
Coupon:4%
Price:Par
Yield:4%
Conversion price:13p
Warrants:75% coverage
Warrant expiration:Five years
Warrant strike price:16p
Investors:Kanter Family Foundation (for $100,000), CIBC Trust Co. (Bahamas) Ltd. (for $100,000), Chicago Investments, Inc. (for $50,000)
Pricing date:Aug. 24
Stock symbol:London: MEDG
Stock price:8.97p at close Aug. 24
Market capitalization:£13.01 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.